PUBLICATIONS

Peer-Reviewed Publications:

  1. Chen Z, Lee BJ, McCulloch CE, Burrows NR, Heung M, Hsu RK, Pavkov ME, Powe NR, Saran R, Shahinian V, Hsu CY; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. The relation between dialysis-requiring acute kidney injury and recovery from end-stage renal disease: a national study. BMC Nephrol. 2019 Sep 2;20(1):342. PubMed PMID: 31477040.

  2. Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis. 2019 Jul;74(1):120-131. doi: 10.1053/j.ajkd.2018.12.044. Epub 2019 Mar 19. Review. PubMed PMID: 30898362.

  3. Gottfried DS, Kagan A, Hoffman BM, Friedman JM. Impeded Rotation of a Protein in a Sol-Gel Matrix. J Phys Chem B. 1999;103:2803-7.

  4. Combs J, Kagan A, Boelkins M, Coscia L, Moritz M, Hofmann RM. Belatacept during pregnancy in renal transplant recipients: Two case reports. Am J Transplant. 2018 Aug;18(8):2079-2082. doi: 10.1111/ajt.14911. Epub 2018 Jun 3. PubMed PMID: 29719109.

  5. Lee BJ, Hsu CY, Parikh RV, Leong TK, Tan TC, Walia S, Liu KD, Hsu RK, Go AS. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study. BMC Nephrol. 2018 Jun 11;19(1):134. PubMed PMID: 29890946.

  6. Lee BJ, Johansen KL, McCulloch CE, Hsu CY. Potential impact of Medicare payment policy on misclassification of dialysis-requiring acute kidney injury as end-stage renal disease: a national temporal trend analysis. Am J Kidney Dis. 2018 Aug;72(2):311-313. Epub 2018 Apr 1. PMID 29615268.

  7. Lee BJ, Go AS, Parikh R, Leong TK, Tan TC, Walia S, Hsu RK, Liu KD, Hsu CY. Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury. Kidney Int. 2018 Jan; PMID 29352593.

  8. Lee BJ, McCulloch CE, Grimes BA, Chandran S, Allen IE, Delgado C, Hsu CY. Refining the policy for timing of kidney transplant waitlist qualification. Transplant Direct. 2017 Aug; 3(8): e195. PMID 28795146.

  9. Lee BJ, Hsu CY. Acute kidney injury is important in the hospital and afterwards. J Hosp Med. 2017 Feb; 12(2):126-127. PMID 28182808.

  10. Lee BJ, Rhee CM, Hsiao LL. Ureteropelvic junction obstruction by an accessory renal artery: an under-recognized but reversible cause of renovascular hypertension. Ann Clin Exp Hypertension. 2015 Sep;3(2):1028.

  11. Hamilton KT, Lee BJ. In-Hospital Delirium While Awaiting Temporal Artery Biopsy: A Teachable Moment. JAMA Intern Med. 2014 Dec;174(12):1891-2. PMID: 25285518.

  12. Olivero JJ, Olivero JJ, Nguyen PT, Kagan A. Acute kidney injury after
    cardiovascular surgery: an overview. Methodist Debakey Cardiovasc J. 2012
    Jul-Sep;8(3):31-6. Review. PubMed PMID: 23227284; PubMed Central PMCID: PMC3487575.

  13. Belden VS, Hirsch EB, Halfon RH, Sirimaturos M, Nguyen PT, Singh R, Liebl MG, Tam VH. Pharmacokinetics of cefepime in critically-ill patients undergoing continuous renal replacement therapy. TSHP Journal. 2012:13(2):5-10.

  14. Chen C, Ochoa LN, Kagan A, Chai H, Liang Z, Lin PH, Yao Q. Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Atherosclerosis. 2012 May;222(1):74-83. doi: 10.1016/j.atherosclerosis.2012.02.010. Epub 2012 Feb 13. PubMed PMID: 22424734; PubMed Central PMCID: PMC3334473.

  15. Olivero JJ, Olivero JJ, Nguyen P, Kagan A. Nephrogenic calcific arteriopathy. Methodist Debakey Cardiovasc J. 2011 Oct-Dec;7(4):33-6. Review. PubMed PMID: 22143475.

  16. Lee BJ, Zand L, Manek NJ, Hsiao LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with reduced activity of muscle lactate dehydrogenase A.  Arthritis Care Res. 2011 Dec; 63(12):1782-6. PMID 22127970.

  17. Nazarian RM, Mandal RV, Kagan A, Kay J, Duncan LM. Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid. J Am Acad Dermatol. 2011 Apr;64(4):741-7. doi: 10.1016/j.jaad.2010.05.034. PubMed PMID: 21414498.

  18. Sucher NJ, Yu E, Chan SF, Miri M, Lee BJ, Xiao B, Worley PF, Jensen FE. Association of the small GTPase Rheb with the NMDA receptor subunit NR3A. Neurosignals. 2010;18(4):203-9. PMID 21135540.

  19. Olivero JJ, Nguyen PT, Olivero JJ, Kagan A. The heart and diabetic
    nephropathy. Methodist Debakey Cardiovasc J. 2010 Apr-Jun;6(2):9-14. Review. PubMed PMID: 20661187.

  20. Kagan A, Sheikh-Hamad D. Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies. Clin Cardiol. 2010 Feb;33(2):62-6. doi: 10.1002/clc.20687. Review. PubMed PMID: 20186983.

  21. Abujudeh HH, Kaewlai R, Kagan A, Chibnik LB, Nazarian RM, High WA, Kay J. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. Radiology. 2009 Oct;253(1):81-9. doi:
    10.1148/radiol.2531082160. Epub 2009 Aug 25. PubMed PMID: 19709997.

  22. Olivero JJ, Nguyen PT, Olivero JJ. Chronic kidney disease: a marker of
    cardiovascular disease. Methodist Debakey Cardiovasc J. 2009;5(2):24-9. Review. PubMed PMID: 20073162.

  23. Olivero JJ, Nguyen PT, Olivero JJ. Vitamin D: cardiovascular effects and beyond. Methodist Debakey Cardiovasc J. 2008;4(3):21-5. Review.

  24. Olivero JJ, Olivero JJ. Serum uric acid: an independent risk factor for vascular injury. Methodist Debakey Cardiovasc J. 2007;4(1):14-6. Review.

  25. Todd DJ, Kagan A, Chibnik LB, Kay J. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum. 2007 Oct;56(10):3433-41. PubMed PMID: 17907148.

  26. Hallene KL, Oby E, Lee BJ, Santaguida S, Bassanini S, Cipolla M, Marchi N, Hossain M, Battaglia G, Janigro D. Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations. Neuroscience. 2006 Sep 29;142(1):267-83. PMID 16859833.

  27. Olivero JJ, Olivero JJ. Ultrafiltration as a Therapeutic Option for Refractory Congestive Heart Failure. Methodist Debakey Cardiovasc J. 2006;2(3):23-6. Review.

  28. Ramanathan V, Nguyen PT, Van Nguyen P, Khan A, Musher D. Successful medical management of recurrent emphysematous pyelonephritis. Urology. 2006 Mar;67(3):623.e11-3. Epub 2006 Feb 28. PubMed PMID: 16504262.

  29. Kagan A, McDonald TV. Dynamic control of hERG/I(Kr) by PKA-mediated
    interactions with 14-3-3. Novartis Found Symp. 2005;266:75-89; discussion 89-99. Review. PubMed PMID: 16050263.

  30. Bian JS, Kagan A, McDonald TV. Molecular analysis of PIP2 regulation of HERG and IKr. Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2154-63. Epub 2004 Jul 1. PubMed PMID: 15231497.

  31. Krumerman A, Gao X, Bian JS, Melman YF, Kagan A, McDonald TV. An LQT mutant minK alters KvLQT1 trafficking. Am J Physiol Cell Physiol. 2004 Jun;286(6):C1453-63. Epub 2004 Feb 4. PubMed PMID: 14761891.

  32. Melman YF, Um SY, Krumerman A, Kagan A, McDonald TV. KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Neuron. 2004 Jun 24;42(6):927-37. PubMed PMID: 15207237.

  33. Cui J, Bian JS, Kagan A, McDonald TV. CaT1 contributes to the stores-operated calcium current in Jurkat T-lymphocytes. J Biol Chem. 2002 Dec
    6;277(49):47175-83. Epub 2002 Oct 1. PubMed PMID: 12361955.

  34. Kagan A, Melman YF, Krumerman A, McDonald TV. 14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity. EMBO J. 2002 Apr 15;21(8):1889-98. PubMed PMID: 11953308; PubMed Central PMCID: PMC125975.

  35. Cui J, Kagan A, Qin D, Mathew J, Melman YF, McDonald TV. Analysis of the
    cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2. J Biol Chem. 2001 May 18;276(20):17244-51. Epub 2001 Feb 26. PubMed PMID: 11278781.

  36. Kagan A, Yu Z, Fishman GI, McDonald TV. The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J Biol Chem. 2000 Apr
    14;275(15):11241-8. PubMed PMID: 10753933.

  37. Gottfried DS, Kagan A, Hoffman BM, Friedman JM. Impeded Rotation of a Protein in a Sol-Gel Matrix. J Phys Chem B. 1999;103:2803-7.

Non-Peer-Reviewed Publications:

  1. Lee BJ, Carles MC, Sucher NJ. Traditional Chinese herbal medicines for the treatment of cardiovascular diseases. A chapter in Botanical Medicine in Clinical Practice. Eds. R.R. Watson and V.R. Preedy. Wallingford, UK: CABI, 2008. 448-462.

Abstracts:

  1. Chen Z, Lee BJ, McCulloch CE, Saran R, Heung M, Pavkov ME, Burrows NR, Hsu CY, CDC CKD Surveillance Team. Geographic correlation between dialysis-requiring AKI and recovery from ESRD. J Am Soc Nephrol 29: 2018; 111-112 (Poster, TH-PO010).

  2. Hsu RK, Rubinsky A, Shlipak M, Peralta CA, Lee BJ, Hsu CY. Association of baseline eGFR and AKI-D with early mortality after ESRD. J Am Soc Nephrol 29: 2018; 28 (Oral, TH-OR100).   

  3. Lee BJ, Johansen KL, McCulloch CE, Hsu CY. Potential impact of CMS payment policy on misclassification of dialysis-requiring acute kidney injury as end-stage renal disease: a national temporal trend analysis. J Am Soc Nephrol 28: 2017; 28 (Oral, TH-OR106).

  4. Lee BJ, Go AS, Parikh R, Leong TK, Tan TC, Walia S, Hsu RK, Liu KD, Hsu CY. Pre-admission proteinuria increases risk of non-recovery after dialysis-requiring acute kidney injury. J Am Soc Nephrol 28: 2017; 422 (Poster, FR-PO088).

  5. Lee BJ, Hsu CY, Parikh R, Leong TK, Tan TC, Walia S, Hsu RK, Liu KD, Go AS. Non-recovery after dialysis-requiring acute kidney injury is associated with increased short-term mortality and cardiovascular events in incident ESRD patients. J Am Soc Nephrol 28: 2017; 433 (Poster, FR-PO128).

  6. Lee BJ, Hsu CY, Parikh R, Leong TK, Tan TC, Walia S, Hsu RK, Liu KD, Go AS. Renal recovery after dialysis-requiring acute kidney injury is associated with decreased short-term mortality. J Am Soc Nephrol 28: 2017; 679 (Poster, SA-PO008).

  7. Lee BJ, McCulloch CE, Grimes BA, Chandran S, Delgado C, Hsu CY. Requiring demonstration of persistently low renal function meaningfully changes timing of kidney transplant waitlist qualification. J Am Soc Nephrol 27: 2016; 714A (Poster, SA-PO374).

  8. Lee BJ, McCulloch CE, Allen IE, Chandran S, Hsu CY. Choice of equation to estimate kidney function has large impact on timing of kidney transplant waitlist qualification. J Am Soc Nephrol 26:2015; 601A-602A (Poster, FR-PO1018). Selected for media promotion at ASN Kidney Week 2015: https://www.asn-online.org/about/press/releases/ASN_PR_20151002_2015KidneyWeekLee38.pdf.

  9. Talos DM, Joseph A, Lee BJ, Meikle L, Sucher NJ, Kwiatkowski DJ, Jensen FE. Synaptic alterations in a mouse model of TSC. Society for Neuroscience Meeting, Chicago, IL. Neuroscience Meeting Planner. Program No. 637.3 /O19 2009 (Poster).

  10. Talos DM, Joseph A, Lee BJ, Meikle L, Kwiatkowski DJ, Jensen FE. Altered glutamatergic synaptic signaling in a TSC mouse model. Epilepsia 50(11):2009; 384 (Poster).

  11. Lee BJ, Mamic P, Sabin JE. Bridging the Gap: medical and dental students advocating for Boston-area refugee and immigrant families. 70th Annual Harvard Medical School Soma Weiss Research Day. Boston, MA. 2010 (Poster).

  12. Kagan A, Wang X, Choi L, Lin P, Yao Q, Chen, CJ. (2008) Visfatin, a marker of endothelial dysfunction and mortality in chronic kidney disease patients, reduces eNOS expression in endothelial cells. 4th Annual Academic Surgical Congress. Fort Myers, FL.

  13. Krumerman A, Kagan A, Melman YF, McDonald TV. (2002) Parallel Trafficking  and Assembly of KvLQT1 and minK. 46th Annual Meeting of the Biophysical Society.  San Francisco, CA.

  14. Kagan A, Krumerman A, McDonald TV. (2002) 14-3-3 Mediates PKA Regulation of the HERG K+ Channel.  46th Annual Meeting of the Biophysical Society.  San Francisco, CA.

  15. Cui J, Qin D, Kagan A, Mathew J, McDonald TV.  (2001) Loss of Function of HERG K+ Channel by Mutations in the Cyclic Nucleotide-binding Domain.  45th Annual Meeting of the Biophysical Society.  Boston, MA.

  16. Kagan A, Zhen M, Fishman GI, McDonald TV. (1999) Dominant Mechanisms in LQT Mutations of HERG.  43rd Annual Meeting of the Biophysical Society.  Baltimore, MD.

  17. Gottfried DS, Kagan A, Friedman JM. (1998) Impeded Rotation of a Protein in a Sol-Gel Matrix. 42nd Annual Meeting of the Biophysical Society.  Kansas City, MI.